FDA Inspection 1271002 — Peter Charles Klatsky, M.D., Inc.
The FDA completed an inspection of Peter Charles Klatsky, M.D., Inc. on May 20, 2025 in Sunnyvale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 20, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Sunnyvale, CA (United States)